site stats

Ctxr sec filings

WebFeb 11, 2024 · Citius Pharmaceuticals, Inc. (CTXR) SEC Filing 10-Q Quarterly report for the period ending Thursday, December 31, 2024. Home. SEC Filings. Citius Pharmaceuticals, Inc. (CTXR) 10-Q Quarterly Report Thu Feb 11 2024; SEC Filings. CTXR Valuations. Intrinsic Value. Financial Stability. Financial Ratios. Insider Trades. WebCitius Pharmaceuticals Inc (NASDAQ:CTXR) institutional ownership structure shows current positions in the company by institutions and funds, as well as latest changes in position …

Citius Pharmaceuticals, Inc. (CTXR) SEC Filing 10-Q Quarterly …

WebAug 11, 2024 · Citius Pharmaceuticals, Inc. (CTXR) SEC Filing 10-Q Quarterly Report for the period ending Thursday, June 30, 2024. Home. SEC Filings. Citius Pharmaceuticals, Inc. (CTXR) 10-Q Quarterly Report Thu Aug 11 2024; SEC Filings. CTXR Valuations. Intrinsic Value. Financial Stability. Financial Ratios. Insider Trades. WebFind the latest Citius Pharmaceuticals, Inc. (CTXR) stock quote, history, news and other vital information to help you with your stock trading and investing. tin verification letter from irs https://ridgewoodinv.com

CTXR - Citius Pharmaceuticals Stock SEC Filings - Barchart.com

WebThese reports include company annual reports (10K, 10Q), news updates (8K), investor presentations (found in 8Ks), insider trades (form 4), ownership reports (13D, and 13G), and reports related to the specific securities sold, such as registration statements and prospectus. This page shows recent SEC filings related to Citius Pharmaceuticals Inc WebCommon stock, $0.001 par value CTXR The Nasdaq Capital Market  Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). Emerging growth company ☐ WebMay 13, 2024 · Citius Pharmaceuticals, Inc. (CTXR) SEC Filing 10-Q Quarterly Report for the period ending Wednesday, March 31, 2024. Home. SEC Filings. Citius Pharmaceuticals, Inc. (CTXR) 10-Q Quarterly Report Thu May 13 2024; SEC Filings. CTXR Valuations. Intrinsic Value. Financial Stability. Financial Ratios. Insider Trades. password to open crif credit report

Citius Pharmaceuticals, Inc. (CTXR) SEC Filing 10-Q Quarterly …

Category:CTXR Citius Pharmaceuticals, Inc. - SeekingAlpha

Tags:Ctxr sec filings

Ctxr sec filings

Citius Pharmaceuticals - CTXR Institutional Ownership

WebDec 12, 2024 · Citius Pharmaceuticals, Inc. (CTXR) SEC Filing 8-K Material Event for the period ending Tuesday, December 11, 2024. Home. SEC Filings. Citius Pharmaceuticals, Inc. (CTXR) 8-K Material Event Wed Dec 12 2024; SEC Filings. CTXR Valuations. Intrinsic Value. Financial Stability. Financial Ratios. Insider Trades. WebApr 6, 2024 · View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations. Get daily stock ideas from top-performing Wall Street analysts.

Ctxr sec filings

Did you know?

WebBack to CTXR Overview Insider Trading information for NDAQ is derived from Forms 3 and 4 filings filed with the U.S. Securities and Exchange Commission (SEC). Please Note: An FPI is exempt... WebFeb 8, 2024 · NASDAQ CTXR opened at $1.42 on Wednesday. Citius Pharmaceuticals, Inc. has a 12 month low of $0.77 and a 12 month high of $2.01. The firm has a market capitalization of $207.62 million, a PE ratio of -6.45 and a beta of 1.41. The company's 50 day simple moving average is $1.11 and its 200 day simple moving average is $1.13.

WebCitius Pharmaceuticals, Inc. Common Stock (CTXR) SEC Filings Nasdaq SEC Filings: CTXR Edit my quotes Citius Pharmaceuticals, Inc. Common Stock (CTXR) 0 Add to Watchlist Add to... WebMay 14, 2024 · Citius Pharmaceuticals, Inc. (CTXR) SEC Filing 10-Q Quarterly report for the period ending Tuesday, March 31, 2024. Home. SEC Filings. Citius Pharmaceuticals, Inc. (CTXR) 10-Q Quarterly Report Thu May 14 2024; SEC Filings. CTXR Valuations. Intrinsic Value. Financial Stability. Financial Ratios. Insider Trades.

WebDec 17, 2024 · Citius Pharmaceuticals, Inc. (CTXR) SEC Filing 10-K Annual report for the fiscal year ending Monday, September 30, 2024. Home. SEC Filings. Citius Pharmaceuticals, Inc. (CTXR) 10-K Annual Report Mon Dec 16 2024; SEC Filings. CTXR Valuations. Intrinsic Value. Financial Stability. Financial Ratios. Insider Trades. WebApr 3, 2024 · Ticker: CTXR CIK: 1506251 Form Type: 8-K Corporate News Accession Number: 0001213900-23-026265 Submitted to the SEC: Mon Apr 03 2024 4:05:20 PM …

WebNov 15, 2024 · Contact Us. Citius Pharmaceuticals, Inc. 11 Commerce Drive, First Floor Cranford, NJ 07016 908-967-6677 [email protected]. follow us on twitter password to open form 16aWebApr 10, 2024 · A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. CTXR shares currently have a short interest ratio of 13.0. Learn More on Citius Pharmaceuticals's short interest ratio. password to open bank of india statementWebMar 31, 2024 · Latest SEC filings for Citius Pharmaceuticals, Inc. (CTXR). Seeking Alpha - Go to Homepage Entering text into the input field will update the search … password to open computer window 10WebApr 6, 2024 · Citius Pharmaceuticals, Inc. SEC Filing - Quarterly Report (10-Q) February 10, 2024 SEC FilingsFri, Feb. 10 Citius Pharmaceuticals, Inc. SEC Filing - Proxy … tin verification portal philippinesWebJan 9, 2024 · Filings & Forms. All companies, foreign and domestic, are required to file registration statements, periodic reports, and other forms electronically through EDGAR. … password to open downloaded aadharWebCTXR Institutional Holdings Ownership Summary Active Positions New and Sold Out Positions 88 Institutional Holders 15,192,898 Total Shares Held Back to CTXR Overview Institutional Holdings... password to open form 16b pdfWebJun 22, 2024 · Citius Pharmaceuticals, Inc. (OTCMKTS:CTXR) Files An 8-K Submission of Matters to a Vote of Security Holders Item 3.03 – Material Modification to Rights of … tin verification slip form online